CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $196,000 | -51.8% | 40,070 | +14.7% | 0.01% | -73.5% |
| Q2 2021 | $407,000 | +31.7% | 34,935 | +37.9% | 0.03% | +21.4% |
| Q1 2021 | $309,000 | +42.4% | 25,334 | +46.2% | 0.03% | +21.7% |
| Q4 2020 | $217,000 | +1.4% | 17,332 | +21.9% | 0.02% | +64.3% |
| Q3 2020 | $214,000 | -46.1% | 14,222 | -12.2% | 0.01% | -50.0% |
| Q2 2020 | $397,000 | +128.2% | 16,193 | +31.8% | 0.03% | +115.4% |
| Q1 2020 | $174,000 | – | 12,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LLC | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |